A team of researchers has developed a new method to calculate and predict how drug molecules in molecular crystals arrange themselves under changing energetic conditions. For pharmaceutical companies, ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Structure Therapeutics’ lead drug candidate is chasing big pharmaceutical rivals in the race for new oral weight-loss medications, and the company had been telling investors to expect data late this ...

DUBLIN--(BUSINESS WIRE)--The "Deuterated Drugs Formulations Therapeutics Markets Strategies" report has been added to Research and Markets' offering. Deuterated Drugs: Products, Pipelines, Strategies, ...

Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...

TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo, Japan; hereinafter referred to as “Elix”) has ...

Structure Therapeutics saw its newly-public U.S. American Depositary Shares (ADSs) rise 70% on their first day of trading, after completing a $161 million initial public offering (IPO)—by far the ...

Shares of Structure Therapeutics Inc. GPCR surged last week after the company announced positive 12-week top-line data from a phase IIa obesity study as well as top-line data from a capsule-to-tablet ...

Capsule-to-tablet study demonstrated a placebo-adjusted mean weight loss of upto 6.9% with the tablet formulation. The company plans to initiate a Phase 2b obesity study of GSBR-1290 in the fourth ...